Rishabh Singh/X
Sep 18, 2025, 07:00
Rishabh Singh on NEJM Letter: FVIII Aurora Mutation Shows Increased Activity and Reduced APC Response
Rishabh Singh, an Heme/Onc fellow at Indiana University, posted on X:
“In a letter to the editor of NEJM, authors describe a naturally occurring FVIII variant, Arg590Ser (designated FVIII Aurora), with substantially increased activity and reduced responsiveness to activated protein C as compared with wild-type FVIII.”
Title: A Naturally Occurring Gain-of-Function Mutation in Factor VIII
Authors: Joshua T. Wischmeyer, Christine H. Baird, Julian Grandvallet Contreras, Alexander Tran, Tzu Phang, Tian Liu, Marilyn J. Manco-Johnson
Read the full version here.
Find similar posts on Hemostasis Today.
-
Mar 20, 2026, 17:47Julie Rayes: Commenting on a Seminal NEJM Study Solving the Mystery of VITT
-
Mar 20, 2026, 17:45William Tembo: Advancing Stroke Care by Validating Acute Ischemic Treatment
-
Mar 20, 2026, 17:37Renjith Vijayakumar Selvarani: New Nanoparticle Approach Clears Brain Plaque and Restores Memory
-
Mar 20, 2026, 17:35Bawan Ahmed: New Evidence May Shift DOAC Choice in Acute DVT Management
-
Mar 20, 2026, 17:17Angelo Cascio Rizzo: CTA-Based Plaque RADS Improves Risk Stratification in ESUS
-
Mar 20, 2026, 17:09Clinical Practice Guidelines for Platelet Transfusion in Non-Surgical and Non-Traumatic Settings – CEBaP
-
Mar 20, 2026, 17:07The Rich Heterogeneity of Platelets and Its Vital Shifts Across Disease States – RPTH
-
Mar 20, 2026, 17:05Pierre Fontana: Launching the European Interuniversity Certificate in Clinical Haemostasis
-
Mar 20, 2026, 16:49Wolfgang Miesbach: A Pivotal Step Forward for Patients with von Willebrand Disease Across All Subtypes